We are live on ! Find out more
MBIO icon

Mustang Bio

25 hedge funds and large institutions have $1.41M invested in Mustang Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

15% more capital invested

Capital invested by funds: $1.22M → $1.41M (+$189K)

0.07% more ownership

Funds ownership: 0.16%0.23% (+0.07%)

4% less funds holding

Funds holding: 2625 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CPA
26
Clear Point Advisors
New York
$1
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
-$36K -351 Closed
Barclays
28
Barclays
United Kingdom
-$8.56K -83 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
-$79 -1 -14%

MBIO Hedge Fund Activity: Q4 2023 in Review

25 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2023, worth a combined $1.41M — up 15% from $1.22M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MBIO and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 5 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $692K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $36K sold.

  • 25 institutional investors held Mustang Bio (MBIO) as of Q4 2023, down from 26 in Q3 2023.
  • Funds reported $1.41M of Mustang Bio stock for Q4 2023, up 15% quarter-over-quarter.
  • 2 funds opened new Mustang Bio positions in Q4 2023 and 3 closed out, a net change of -1 holder.
  • The largest Mustang Bio buyer in Q4 2023 was Armistice Capital, an estimated $692K added.
  • The largest Mustang Bio seller in Q4 2023 was Dimensional Fund Advisors, an estimated $36K sold.

Based on aggregated 13F filings for Q4 2023.